- Home
- RVTY vs ASND Comparison
RVTY vs ASND Comparison
Compare RVTY & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVTY | ASND |
|---|---|---|
| Founded | 1937 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 13.2B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | RVTY | ASND |
|---|---|---|
| Price | $117.74 | $228.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 16 |
| Target Price | $113.46 | ★ $264.13 |
| AVG Volume (30 Days) | ★ 1.2M | 557.2K |
| Earning Date | 02-02-2026 | 02-11-2026 |
| Dividend Yield | ★ 0.24% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.99 | N/A |
| Revenue | ★ $2,813,367,000.00 | $758,592,045.00 |
| Revenue This Year | $5.30 | $99.54 |
| Revenue Next Year | $3.03 | $84.40 |
| P/E Ratio | $58.51 | ★ N/A |
| Revenue Growth | 3.37 | ★ 97.46 |
| 52 Week Low | $81.36 | $118.03 |
| 52 Week High | $128.29 | $229.94 |
Technical Indicators
Market Signals| Indicator | RVTY | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 72.70 | 62.13 |
| Support Level | $110.17 | $200.69 |
| Resistance Level | $115.78 | $221.75 |
| Average True Range (ATR) | 4.18 | 12.01 |
| MACD | 1.41 | 1.12 |
| Stochastic Oscillator | 96.73 | 80.19 |
Price Performance
Historical ComparisonAbout RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.